nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal glucose metabolism in patients with Fontan circulation: Unique characteristics and associations with Fontan pathophysiology
|
Ohuchi, Hideo |
|
2019 |
216 |
C |
p. 125-135 |
artikel |
2 |
Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry
|
Faridi, Kamil F. |
|
2019 |
216 |
C |
p. 53-61 |
artikel |
3 |
Amyloid cardiomyopathy in a large integrated health care system
|
Czobor, Peter |
|
2019 |
216 |
C |
p. 42-52 |
artikel |
4 |
Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial
|
Joshi, Rajnish |
|
2019 |
216 |
C |
p. 9-19 |
artikel |
5 |
Clinical effects of cyclosporine in acute anterior myocardial infarction complicated by heart failure: A subgroup analysis of the CIRCUS Trial
|
Claeys, Marc J |
|
2019 |
216 |
C |
p. 147-149 |
artikel |
6 |
Correction to “Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease”, [American Heart Journal (December 2018) 51-60]
|
|
|
2019 |
216 |
C |
p. 150 |
artikel |
7 |
Direct oral anticoagulant– versus vitamin K antagonist–related gastrointestinal bleeding: Insights from a nationwide cohort
|
Butt, Jawad H. |
|
2019 |
216 |
C |
p. 117-124 |
artikel |
8 |
Editorial Board
|
|
|
2019 |
216 |
C |
p. iv |
artikel |
9 |
Erratum to “Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA)” [Am Heart J (2019) 30–34]
|
Decker, Paul A. |
|
2019 |
216 |
C |
p. 151 |
artikel |
10 |
Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI Registry
|
Jones, W. Schuyler |
|
2019 |
216 |
C |
p. 74-81 |
artikel |
11 |
High prevalence of cholesterol-rich atherosclerotic lesions in ancient mummies: A near-infrared spectroscopy study
|
Madjid, Mohammad |
|
2019 |
216 |
C |
p. 113-116 |
artikel |
12 |
High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post–myocardial infarction patients
|
Fu, Edouard L. |
|
2019 |
216 |
C |
p. 20-29 |
artikel |
13 |
Identification, diagnosis, treatment, and in-hospital outcomes of acute pulmonary embolism: Results from a single integrated health system
|
Holder, Tara |
|
2019 |
216 |
C |
p. 136-142 |
artikel |
14 |
Information for Readers
|
|
|
2019 |
216 |
C |
p. v |
artikel |
15 |
Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction
|
Mok, Yejin |
|
2019 |
216 |
C |
p. 62-73 |
artikel |
16 |
Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD)
|
Okeke, Nwora Lance |
|
2019 |
216 |
C |
p. 91-101 |
artikel |
17 |
Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease
|
Cannon, Christopher P. |
|
2019 |
216 |
C |
p. 30-41 |
artikel |
18 |
Surgical timing in infective endocarditis complicated by intracranial hemorrhage
|
Venn, Rachael A. |
|
2019 |
216 |
C |
p. 102-112 |
artikel |
19 |
Table of Contents
|
|
|
2019 |
216 |
C |
p. i-iii |
artikel |
20 |
Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission
|
Vroegindewey, Maxime M. |
|
2019 |
216 |
C |
p. 143-146 |
artikel |
21 |
The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale
|
Mauri, Laura |
|
2019 |
216 |
C |
p. 82-90 |
artikel |
22 |
The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to Whites: The Atherosclerosis Risk in Communities (ARIC) study
|
Loehr, Laura R. |
|
2019 |
216 |
C |
p. 1-8 |
artikel |